Equities, Investment & Market Trends
DEA Assigns New Drug Code to Hexahydrocannabinol (HHC), Reaffirming Schedule I Status
The DEA clarifies hexahydrocannabinol (HHC) is a federally illegal Schedule I substance, assigning it a new drug code. This synthetic cannabinoid does not…
Equities, Investment & Market Trends
Texas Industrial Hemp Industry Challenges State Ban on Smokable Products and Increased Licensing Fees
Texas industrial hemp businesses are challenging state regulations banning smokable products and increasing licensing fees. Learn how these proposed rules…
Equities, Investment & Market Trends
CAURD Inc. Outlines Plan to Stabilize New York’s Equity Cannabis Market
CAURD Inc. outlined a three-point plan to stabilize New York's equity cannabis market. This advocacy aims to refine cannabis policy and ensure market viab…
Australian Cannabis Policy & Law
Potential US Federal Medical Cannabis Reclassification Could Reshape Market Dynamics for Marketers and Industry
Explore how potential US federal medical cannabis reclassification could impact market dynamics, regulatory frameworks, and commercialisation strategies f…
Equities, Investment & Market Trends
Florida Regulators Address Alleged Environmental Violations at Trulieve Cultivation Site
Florida regulators have cited multi-state operator Trulieve for alleged environmental violations at a cannabis cultivation site. Learn about the specific…
Access & Prescribing (Australia & Global)
US Justice Department Order Reclassifies Medical Cannabis, Impacts Dispensary Operations and Patient Access
The US Justice Department's recent order reclassifies medical cannabis, removing it from Schedule I. This move impacts dispensaries' tax obligations, pati…
Access & Prescribing (Australia & Global)
Defensible Medical Cannabis Pricing Data Critical for Litigation and Market Integrity
Understanding the importance of defensible medical cannabis pricing data is crucial for investors and operators navigating legal disputes and market valua…
Access & Prescribing (Australia & Global)
New Zealand Sees Significant Increase in Medicinal Cannabis Prescriptions Amidst Evolving Market Dynamics
New Zealand's medicinal cannabis prescriptions surged to 44% of users in 2025, driven by clinics and online access. Explore the market shifts, pricing tre…
Australian Cannabis Policy & Law
US Industrial Hemp Sector Faces Regulatory Challenges Post-2018 Farm Bill Implementation
Explore the regulatory complexities impacting the US industrial hemp sector after the 2018 Farm Bill. Understand how market dynamics and policy gaps chall…
Equities, Investment & Market Trends
Portnoy Law Firm Initiates Securities Fraud Investigation into Sndl Following Stock Decline
Portnoy Law Firm has launched a securities fraud investigation into cannabis company Sndl after its stock price fell on December 15. Learn about the poten…
